Shijiazhuang Yiling Pharmaceutical Co., Ltd. Shijiazhuang Yiling Pharmaceutical Co., Ltd.

Shijiazhuang Yiling Pharmaceutical Co., Ltd.

002603

Rank in Stocks #4269
Shijiazhuang Yiling Pharmaceutical Co., Ltd. engages in the research and... Shijiazhuang Yiling Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of Chinese medicine primarily in China. It offers drugs for cardiovascular and cerebrovascular, respiratory, endocrine, neurological, digestive, immune, and urinary diseases, diabetes mellitus, oncology, sleep-improving, and anti-aging. The company also provides dietary supplements, disinfection products, personal protective equipment, as well as formula granules. Shijiazhuang Yiling Pharmaceutical Co., Ltd. was founded in 1992 and is based in Shijiazhuang, China.
Share Price
$2.24
Market Cap
$3.74B
Change (1 day)
0.65%
Change (1 year)
-8.57%
Country
CN
Trade Shijiazhuang Yiling Pharmaceutical Co., Ltd. (002603)

Category

Healthcare
P/B ratio for Shijiazhuang Yiling Pharmaceutical Co., Ltd. (002603)
P/B ratio as of October 2026 TTM: 2.30
According to Shijiazhuang Yiling Pharmaceutical Co., Ltd. latest financial reports and stock price the company's current price-to-book ratio (TTM) is 2.30. At the end of 2023 the company had a P/B ratio of 3.37.
P/B ratio history for Shijiazhuang Yiling Pharmaceutical Co., Ltd. from 2008 to 2026
P/B ratio at the end of each year
Year P/B Ratio Change
2026 (TTM) 2.30 -12.10%
2024 2.62 -22.28%
2023 3.37 -26.48%
2022 4.58 26.81%
2021 3.61 5.85%
2020 3.41 82.65%
2019 1.87 19.92%
2018 1.56 -36.50%
2017 2.45 -31.76%
2016 3.59 -13.52%
2015 4.16 17.24%
2014 3.54 -17.08%
2013 4.27 29.26%
2012 3.31 -17.86%
2011 4.03 -70.70%
2010 13.74 -26.60%
2009 18.72 -38.84%
2008 30.61 0.00%
P/B ratio for similar companies or competitors